Availability of Donor Milk for Very Preterm Infants Decreased the Risk of Necrotizing Enterocolitis without Adversely Impacting Growth or Rates of Breastfeeding

Nutrients. 2019 Aug 14;11(8):1895. doi: 10.3390/nu11081895.

Abstract

Human milk contains non-nutritional factors that promote intestinal maturation and protect against infectious and inflammatory conditions. In the Neonatal Intensive Care Unit (NICU) setting, donor milk (DM) is recommended when availability of own mother's milk (OMM) is not enough. Our aim was to compare the incidence of necrotizing enterocolitis (NEC) and late-onset sepsis (LOS) in very preterm infants (VPI) after the introduction of DM. Growth and breastfeeding rates were examined as secondary outcomes. Single center, observational and retrospective cohort study comparing 227 VPI admitted to our neonatal unit before (Group 1, n = 99) and after (Group 2, n = 128) DM introduction. Enteral nutrition was started earlier after DM availability (2.6 ± 1.1 vs. 2.1 ± 1 days, p = 0.001). Incidence of NEC decreased in group 2 (9.1% vs. 3.4%, p = 0.055), especially in those born between 28 and 32 weeks (5.4 vs. 0.0%, p = 0.044). Surgical NEC was also less frequent. Suffering NEC was 4 times more likely in group 1 (multivariate analysis). Availability of DM did not impact breastfeeding rates or preterm growth. Our findings support the protective role of DM against NEC, particularly in non-extreme VPI, a group less frequently included in clinical guidelines and research studies on the use of DM.

Keywords: breastfeeding; donor human milk; formula feeding; growth; human milk; necrotizing enterocolitis; preterm infant.

Publication types

  • Observational Study

MeSH terms

  • Age Factors
  • Birth Weight*
  • Bottle Feeding*
  • Breast Milk Expression*
  • Child Development*
  • Enterocolitis, Necrotizing / epidemiology
  • Enterocolitis, Necrotizing / physiopathology
  • Enterocolitis, Necrotizing / prevention & control*
  • Gestational Age
  • Humans
  • Incidence
  • Infant, Newborn
  • Infant, Premature / growth & development*
  • Milk, Human*
  • Neonatal Sepsis / epidemiology
  • Neonatal Sepsis / physiopathology
  • Neonatal Sepsis / prevention & control
  • Nutritive Value
  • Protective Factors
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Spain / epidemiology